PURPOSE: Although beneficial effects of the dietary n-3 docosahexaenoic acid (DHA) or butyrate in colon carcinogenesis have been implicated, the mechanisms of their action are not fully clear. Here, we investigated modulations of composition of individual phospholipid (PL) classes, with a particular emphasis on cardiolipins (CLs), in colon cells treated with DHA, sodium butyrate (NaBt), or their combination (DHA/NaBt), and we evaluated possible associations between lipid changes and cell fate after fatty acid treatment. METHODS: In two distinct human colon cell models, foetal colon (FHC) and adenocarcinoma (HCT-116) cells, we compared patterns and composition of individual PL classes following the fatty acid treatment by HPLC-MS/MS. In parallel, we measured the parameters reflecting cell proliferation, differentiation and death. RESULTS: In FHC cells, NaBt induced primarily differentiation, while co-treatment with DHA shifted their response towards cell death. In contrast, NaBt induced apoptosis in HCT-116 cells, which was not further affected by DHA. DHA was incorporated in all main PL types, increasing their unsaturation, while NaBt did not additionally modulate these effects in either cell model. Nevertheless, we identified an unusually wide range of CL species to be highly increased by NaBt and particularly by DHA/NaBt, and these effects were more pronounced in HCT-116 cells. DHA and DHA/NaBt enhanced levels of high molecular weight and more unsaturated CL species, containing DHA, which was specific for either differentiation or apoptotic responses. CONCLUSIONS: We identified a wide range of CL species in the colon cells which composition was significantly modified after DHA and NaBt treatment. These specific CL modulations might contribute to distinct cellular differentiation or apoptotic responses.

Department of Cytokinetics Institute of Biophysics of the Czech Academy of Sciences Brno Czech Republic

Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic

Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic

Veterinary Research Institute v v i Brno Czech Republic

See more in PubMed

J Nutr Biochem. 2007 Nov;18(11):736-45 PubMed

Arch Biochem Biophys. 1999 Aug 1;368(1):45-55 PubMed

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):186-99 PubMed

Biofactors. 2009 Sep-Oct;35(5):460-7 PubMed

Biochim Biophys Acta. 2015 Jan;1848(1 Pt B):211-9 PubMed

Reprod Nutr Dev. 2005 Sep-Oct;45(5):559-79 PubMed

Chem Biol Interact. 2006 Oct 27;163(1-2):15-28 PubMed

J Nutr. 2002 May;132(5):1012-7 PubMed

Mol Cancer. 2013 Nov 21;12 (1):145 PubMed

Curr Pharm Biotechnol. 2013;14(3):274-88 PubMed

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 25;823(1):26-36 PubMed

Neuro Endocrinol Lett. 2009;30 Suppl 1:121-7 PubMed

J Bioenerg Biomembr. 2014 Oct;46(5):447-57 PubMed

FASEB J. 2014 Oct;28(10):4247-64 PubMed

Ann N Y Acad Sci. 2015 Sep;1350:77-81 PubMed

Curr Med Chem. 2007;14(29):3059-69 PubMed

Biochim Biophys Acta. 2014 Sep;1841(9):1308-17 PubMed

Eur J Cancer. 2000 Sep;36(14):1844-52 PubMed

Carcinogenesis. 2005 Jun;26(6):1064-76 PubMed

Mediators Inflamm. 2014;2014:848632 PubMed

FASEB J. 2006 Apr;20(6):770-2 PubMed

Curr Opin Clin Nutr Metab Care. 2012 Mar;15(2):122-6 PubMed

Biochem Biophys Res Commun. 2014 Jul 18;450(1):366-71 PubMed

J Bioenerg Biomembr. 2012 Aug;44(4):439-52 PubMed

Mol Cell. 2012 Nov 30;48(4):612-26 PubMed

Mitochondrion. 2014 May;16:55-64 PubMed

Cancer Res. 2003 Oct 1;63(19):6311-9 PubMed

J Nutr. 2003 Nov;133(11):3509-15 PubMed

Int J Mol Sci. 2012 Nov 21;13(11):15447-63 PubMed

J Nutr. 2002 Dec;132(12):3804S-3808S PubMed

Biochem Cell Biol. 2004 Feb;82(1):18-26 PubMed

Eur J Nutr. 2010 Apr;49(3):133-9 PubMed

J Nutr. 1993 Nov;123(11):1808-17 PubMed

BMC Biochem. 2005 Mar 24;6:5 PubMed

J Nutr. 2004 Dec;134(12 ):3233-8 PubMed

Biophys J. 2015 Sep 15;109(6):1282-94 PubMed

Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19 PubMed

J Biol Chem. 2006 May 12;281(19):13548-58 PubMed

Chem Phys Lipids. 2008 May;153(1):14-23 PubMed

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1903-7 PubMed

Eur J Nutr. 2000 Aug;39(4):164-71 PubMed

Nutr Res Rev. 2004 Dec;17(2):177-92 PubMed

Am J Physiol Gastrointest Liver Physiol. 2002 Aug;283(2):G340-6 PubMed

Biochim Biophys Acta. 1993 Apr 7;1167(2):131-6 PubMed

Biochim Biophys Acta. 2010 Aug;1797(8):1555-62 PubMed

Biochim Biophys Acta. 2009 Oct;1788(10):2022-31 PubMed

Int J Cancer. 2008 Oct 15;123(8):1974-7 PubMed

Am J Physiol Cell Physiol. 2007 Jan;292(1):C33-44 PubMed

Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):427-32 PubMed

Can J Biochem Physiol. 1959 Aug;37(8):911-7 PubMed

Cancer Metastasis Rev. 2011 Dec;30(3-4):325-42 PubMed

Apoptosis. 2007 May;12(5):877-85 PubMed

Eur J Nutr. 2005 Feb;44(1):40-51 PubMed

FEBS J. 2006 Jun;273(12):2749-65 PubMed

J Lipid Res. 2008 Dec;49(12):2545-56 PubMed

Adv Med Sci. 2007;52:83-8 PubMed

Curr Pharm Des. 2009;15(36):4103-16 PubMed

Cancer Res. 2007 Jun 1;67(11):5561-8 PubMed

Eur J Biochem. 2000 Nov;267(21):6435-42 PubMed

Mol Nutr Food Res. 2008 Aug;52(8):885-97 PubMed

Prog Lipid Res. 2013 Oct;52(4):513-28 PubMed

J Nutr Biochem. 2012 Jun;23(6):539-48 PubMed

J Nutr Biochem. 2004 Nov;15(11):700-6 PubMed

Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50 PubMed

Mol Nutr Food Res. 2009 May;53 Suppl 1:S102-13 PubMed

Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples

Colon Cancer and Perturbations of the Sphingolipid Metabolism